Skip to search formSkip to main contentSkip to account menu

PYM50028

Known as: PYM 50028, PYM-50028 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

sarsasapogenin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
The ongoing pursuit of neuroprotective therapies in Parkinson disease
Many agents developed for neuroprotective treatment of Parkinson disease (PD) have shown great promise in the laboratory, but… 
2013
2013
Reversal of dopamine neurons and locomotor ability degeneration in aged rats with smilagenin
Review
2013
Review
2013
How to treat Parkinson's disease in 2013.
  • P. Worth
  • Clinical medicine
  • 2013
  • Corpus ID: 46221158
Parkinson's disease is a common, progressive, debilitating disease with substantial physical, psychological and social… 
Review
2012
Review
2012
Stem cells and regenerative therapies for Parkinson's disease.
Currently the mainstay of Parkinson's disease (PD) therapy is the pharmacological replacement of the loss of the dopaminergic… 
2010
2010
Parkinson's disease and related disorders--XVIII WFN World Congress.
  • D. Grosset
  • IDrugs : the investigational drugs journal
  • 2010
  • Corpus ID: 6972601
The XVIII World Federation of Neurology (WFN) World Congress on Parkinson's Disease and Related Disorders, held in Miami, FL, USA… 
2010
2010
The Movement Disorder Society--14th International Congress of Parkinson's Disease and Movement Disorders.
The 14th International Congress of Parkinson's Disease and Movement Disorders, held in Buenos Aires, included topics covering new… 
Highly Cited
2008
Highly Cited
2008
PYM50028, a novel, orally active, nonpeptide neurotrophic factor inducer, prevents and reverses neuronal damage induced by MPP+ in mesencephalic neurons and by MPTP in a mouse model of Parkinson's…
Many experimental data support the enhancement of neurotrophic factors as a means to modify neurodegeneration in Parkinson's… 
2005
2005
Natural Products in Drug Discovery and Development. 27-28 June 2005, London, UK.
  • A. Harvey
  • IDrugs : the investigational drugs journal
  • 2005
  • Corpus ID: 41752843
The meeting covered many aspects of the use of natural products in drug discovery and development. The historical and current… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License